<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2021-32-10-15</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-2333</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭПИДЕМИОЛОГИЯ И ГИГИЕНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EPIDEMIOLOGY AND HYGIENE</subject></subj-group></article-categories><title-group><article-title>Clostridium perfringens – антибиотико-ассоциированные и спорадические диареи у детей: возрастные, анамнестические и клинико-лабораторные характеристики</article-title><trans-title-group xml:lang="en"><trans-title>Clostridium perfringens – antibiotic-associated and sporadic diarrhea in children: age, anamnestic and clinical and laboratory features</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8939-2973</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кветная</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kvetnaya</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кветная Ася Степановна, д. м. н., проф., в. н. с. научно-исследовательского отдела медицинской микробиологии и молекулярной микробиологии</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Kvetnaya Asya S., DM Sci (habil.), professor, leading researcher at Research Dept of Medical Microbiology and Molecular Microbiology</p><p>Saint Petersburg</p></bio><email xlink:type="simple">asya41@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8071-3243</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Железова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhelezova</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Железова Людмила Ильинична, к. м. н., с. н. с. научно-исследовательского отдела медицинской микробиологии и молекулярной микробиологии</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Zhelezova Lyudmila I., PhD Med, senior researcher at Research Dept of Medical Microbiology and Molecular Microbiology</p><p>Saint Petersburg</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pediatric Research and Clinical Centre for Infectious Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>16</day><month>12</month><year>2021</year></pub-date><volume>0</volume><issue>32</issue><issue-title>Эпидемиология, гигиена, инфекционные болезни (2)</issue-title><fpage>10</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кветная А.С., Железова Л.И., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Кветная А.С., Железова Л.И.</copyright-holder><copyright-holder xml:lang="en">Kvetnaya A.S., Zhelezova L.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/2333">https://www.med-alphabet.com/jour/article/view/2333</self-uri><abstract><p>В статье представлены результаты собственных исследований по проблеме двух клинических форм диареи у детей (спорадической и антибиотико-ассоциированной диареи – ААД), не связанных с пищей, обусловленных энтеропродуцирующими штаммами Clostridium perfringens (C. perfringens – Ср). В рамках разработанного алгоритма в ФГБУ «ДНКЦИБ ФМБА России» (Санкт-Петербург) проведен анализ результатов комплексного клинико-лабораторного обследования детей в возрасте от 2 месяцев до 18 лет с диареей (ОКИ, n = 406 детей) в 2019–2021 годах. Материалом для исследования служили пробы кала, копрофильтраты и штаммы микроорганизмов, определяющих микробиоценоз кишечника, в том числе энтеротоксигенные штаммы C. perfringens. Основную группу составили дети с диареей (n = 38 из 406; 9,35 ± 1,8 %), у которых при поступлении в копрофильтратах обнаруживали энтеротоксин C. perfringens в ИФА и из проб кишечного содержимого выделялись культуры энтеротоксигенных штаммов C. perfringens. В первую группу вошли дети (n = 30 из 406; 7,4 ± 1,8 %) с антибиотико-ассоциированной диареей, во вторую – дети (n = 8 из 406, 1,9 ± 1,9 % детей) со спорадической диареей. В структуре энтеротоксигенных C. perfringens – ассоциированных ААД (n = 38) составила 78,9 %, спорадическая – 21,1 %. Достоверно чаще ААД регистрировалась у детей в возрасте до 1 года, спорадическая – у всех детей старше 8 лет (р &lt; 0,05). У всех больных ААД и у всех детей со спорадической диареей тяжесть течения и выраженность диарейного синдрома напрямую зависели от колонизационной активности (КОЕ/г) энтеротоксигенных C. perfringens (r = 0,78). Заболевание у больных ААД и спорадической диареей протекало преимущественно с синдромами гастроэнтерита, энтероколита и гемоколита. Случаи спорадической диареи отличались тяжелым и длительным характером течения, развитием глубоких декомпенсированных нарушений микробиоты толстой кишки, ассоциированных с высокой колонизационной активностью как энтеротоксигенных штаммов C. perfringens (КОЕ / г = 106–7), так и условно патогенных микроорганизмов Klebsiella spp., Staphylococcus aureus и Candida albicans (КОЕ / г = 106–7), (р &lt; 0,05). Полученные результаты определяют тактику дифференциальной диагностики и лечения ААД и спорадических диарей, вызванных энтеропродуцирующими штаммами C. perfringens.</p></abstract><trans-abstract xml:lang="en"><p>The article presents the data of the research on the problem of two clinical forms of enteroproducing Clostridium perfringens (C. perfringens) – associated infection in the children who are not connected with food – antibiotic-associated and sporadic forms. Within the period of 2019–2021 a retrospective analysis of the results of complex clinical and laboratory study of children aged from 2 months to 18 years with diarrhea (acute intestinal infection, n = 406 children) was carried out within the framework of the algorithm developed by Pediatric Research and Clinical Center for Infectious Diseases (Russia, Saint Petersburg). The material for the study included stool tests, coprofiltrates and strains of the microorganisms determinating microbiocoenosis of the intestines including enterotoxigenic strains of C. perfringens. The main group included children with diarrhea (n = 38 of 406 children with diarrhea) who at admission presented C. perfringens enterotoxin in coprofiltrates found by immune-enzyme analysis and there were identified the cultures of enterotoxigenic strains of C. perfringens by tests of intestinal contents. The first group included children (n = 30 of 406 children; 7 %) with antibiotic-associated diarrhea (AAD). The second group included children (n = 8 of 406 children; 2 %) with sporadic diarrhea. An overwhelming majority of patients with ААD (n = 20; 92.3 %) of the first 8 (100 %) years of life presented intensity of diarrhea syndrome in direct dependence on colonization activity of enterotoxigenic C perfringens (colony-forming units/g feces) (r = 0.78). The disease proceeded mainly with the syndromes of gastroenteritis, enterocolitis and hemorrhagic colitis. There was noted a reliable high frequency of severe forms of both ААD, and sporadic diarrhea (р &lt; 0.05) caused by enterotoxigenic strains of C perfringens in children of the first year of life. Deep decompensated disorders of large intestine microbiota associated with Klebsiella spp., Staphylococcus aureus and Candida albicans, were characterized by severity and prolonged character of the course (р &lt; 0.05). The received results determine the tactics of differential diagnosis and treatment of AAD and sporadic diarrhea caused by enteroproducing strains of C. perfringens.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>C. perfringens</kwd><kwd>энтеротоксин</kwd><kwd>микробиота</kwd><kwd>ААД и спорадическая диарея</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>C. perfringens</kwd><kwd>enterotoxin</kwd><kwd>microbiota</kwd><kwd>ААD and sporadic diarrhea</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мазанкова Л. В.,Чеботарева Т. А., Горбунов С. Б. и др. Дифференцированный подход к этиологической диагностике острой диареи у детей в эпидсезон клинические случаи. Журнал Фарматека, 2020. Т. 27. № 9. С. 103–107.</mixed-citation><mixed-citation xml:lang="en">Mazankova L. V., Chebotareva T. A., Gorbunov S. B. et al. Differentiated approach to the etiological diagnosis of acute diarrhea in children during the epidemiological season of clinical cases. Pharmateca Journal, 2020. T. 27. No. 9. P. 103–107.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Успенский Ю. П., Фоминых Ю. А. Антибиотик-ассоциированная диарея: актуальность проблемы, профилактика и терапия. Архивъ внутренней медицины. № 2 (10). 2013. С. 46–53.</mixed-citation><mixed-citation xml:lang="en">Uspensky Yu.P., Fominykh Yu. A. Antibiotic-associated diarrhea: relevance of the problem, prevention and therapy. Archives of Internal Medicine. No. 2 (10). 2013. S. 46–53.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kiu R., Hall LJ. An update on the human and animal enteric pathogen Clostridium perfringens. Emerg Microb Infect. 2018; 7(1): 141.</mixed-citation><mixed-citation xml:lang="en">Kiu R., Hall LJ. An update on the human and animal enteric pathogen Clostridium perfringens. Emerg Microb Infect. 2018; 7(1): 141.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Alam S., Muchatag M. Antibiotic associated diarrhea in children. Indian Pеdiatr. 2009. Vol. 46, No. 6. Р. 491–496.</mixed-citation><mixed-citation xml:lang="en">Alam S., Muchatag M. Antibiotic associated diarrhea in children. Indian Pеdiatr. 2009. Vol. 46, No. 6. Р. 491–496.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hobbs B. C., Smith M. T., Oakley C. L., Warrack G. H., Cruickshank J. C. Clostridium welchii food poisoning. J. Hyg. 1953; 51: 75–101. DOI: 10.1017/S 0022172400015515.[PMC free article] [PubMed] [CrossRet] [Google Scholar].</mixed-citation><mixed-citation xml:lang="en">Hobbs B. C., Smith M. T., Oakley C. L., Warrack G. H., Cruickshank J. C. Clostridium welchii food poisoning. J. Hyg. 1953; 51: 75–101. DOI: 10.1017/S 0022172400015515.[PMC free article] [PubMed] [CrossRet] [Google Scholar].</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">McClane B.A.; Uzal F. A.; Miyakawa M. F.; Lyerly D.; Wilkins T. D. The enterotoxic clostridia. In The Prokan/otes, 3rd ed.; Dworkin M., Falkow S., Rosenburg E., Schleifer H., Stackebrandt E., Eds.; Springer NY Press.: New York, NY, USA, 2006; pp. 688–752.</mixed-citation><mixed-citation xml:lang="en">McClane B.A.; Uzal F. A.; Miyakawa M. F.; Lyerly D.; Wilkins T. D. The enterotoxic clostridia. In The Prokan/otes, 3rd ed.; Dworkin M., Falkow S., Rosenburg E., Schleifer H., Stackebrandt E., Eds.; Springer NY Press.: New York, NY, USA, 2006; pp. 688–752.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Freedman J. C., A. Shrestha. Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Application. Future Microbiol. 2016, 8, 73.</mixed-citation><mixed-citation xml:lang="en">Freedman J. C., A. Shrestha. Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Application. Future Microbiol. 2016, 8, 73.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rood J. I. et al. Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe (2018) 10.1016/j.anaerobe.2018.04.011.</mixed-citation><mixed-citation xml:lang="en">Rood J. I. et al. Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe (2018) 10.1016/j.anaerobe.2018.04.011.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gilbert R. J. Cholesterol dependent cytolysins. Adv. Exp. Med. Biol. 2010; 677: 56–66. https://doi.org/10.1007/978–1–4419–63277–5.</mixed-citation><mixed-citation xml:lang="en">Gilbert R. J. Cholesterol dependent cytolysins. Adv. Exp. Med. Biol. 2010; 677: 56–66. https://doi.org/10.1007/978–1–4419–63277–5.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Llanco LA., Nakano V., Avila-Campos M. J. Sialidase production and genetic diversity in Clostridium perfringens type A isolated from chicken with necrotic enteritis in Brazil. Curr. Microbiol. 2015; 70 (3): 330–7. https://doi.org/10.1007/s00284–014–0722–5.</mixed-citation><mixed-citation xml:lang="en">Llanco LA., Nakano V., Avila-Campos M. J. Sialidase production and genetic diversity in Clostridium perfringens type A isolated from chicken with necrotic enteritis in Brazil. Curr. Microbiol. 2015; 70 (3): 330–7. https://doi.org/10.1007/s00284–014–0722–5.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kiu R., Caim S., Alexander S., Pachori P., Hall L. J. Probing genomic aspects of the multihost pathogen Clostridium perfringens reveals significant pangenome diversity, and a diverse array of virulence factors. Front. Microbiol. 2017; 8; 2485. https://doi.org/10.3389/fmicb.2017.0248.</mixed-citation><mixed-citation xml:lang="en">Kiu R., Caim S., Alexander S., Pachori P., Hall L. J. Probing genomic aspects of the multihost pathogen Clostridium perfringens reveals significant pangenome diversity, and a diverse array of virulence factors. Front. Microbiol. 2017; 8; 2485. https://doi.org/10.3389/fmicb.2017.0248.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., McClane B. A. NanI sialidase can support the growth and survival of Clostridium perfringens strain F4969 using sialyated host macromolecules (Mucin) or Caco‑2 cells. Infect. Immun. 2018; 86 (2): e00547–17. https://doi.org/10.1128/iai.00547-17.</mixed-citation><mixed-citation xml:lang="en">Li J., McClane B. A. NanI sialidase can support the growth and survival of Clostridium perfringens strain F4969 using sialyated host macromolecules (Mucin) or Caco‑2 cells. Infect. Immun. 2018; 86 (2): e00547–17. https://doi.org/10.1128/iai.00547-17.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yan X., Porter C. J., Hardy S. P., Steer D., Smith A. I., Quinsey N. S., et al. Structural and functional analysis of the pore-forming toxin NetB from Clostridium perfringens. mBio. 2013; 4(1): e00019–13. https://doi.org/10.1128/mbio.00019-13.</mixed-citation><mixed-citation xml:lang="en">Yan X., Porter C. J., Hardy S. P., Steer D., Smith A. I., Quinsey N. S., et al. Structural and functional analysis of the pore-forming toxin NetB from Clostridium perfringens. mBio. 2013; 4(1): e00019–13. https://doi.org/10.1128/mbio.00019-13.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wisniewski J. A., Rood J. I. The Tcp conjugation system of Clostridium perfringens. Plasmid. 2017; 91: 28–36. https://doi.org/10.1016/j.plasmid.2017.03.001.</mixed-citation><mixed-citation xml:lang="en">Wisniewski J. A., Rood J. I. The Tcp conjugation system of Clostridium perfringens. Plasmid. 2017; 91: 28–36. https://doi.org/10.1016/j.plasmid.2017.03.001.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Adams B., Bannam T., Mijmoto K. Et al. Toxin plasmids of Clostridium perfringens. Microbiol Mol Biol Rev. 2013 Jun; 77 (2): 208–233. DOI: 10.1128/MMBR. 00062–12.</mixed-citation><mixed-citation xml:lang="en">Li J., Adams B., Bannam T., Mijmoto K. Et al. Toxin plasmids of Clostridium perfringens. Microbiol Mol Biol Rev. 2013 Jun; 77 (2): 208–233. DOI: 10.1128/MMBR. 00062–12.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kiu R., Brown J., Bedwell H., Leclaire1 C. et al. Genomic analysis on broiler-associated Clostridium perfringens strains and exploratory caecal microbiome investigation reveals key factors linked to poultry necrotic enteritis. Animal Microbiome (2019) 1: 12. https://doi.org/10.1186/s42523-019-0015-1.</mixed-citation><mixed-citation xml:lang="en">Kiu R., Brown J., Bedwell H., Leclaire1 C. et al. Genomic analysis on broiler-associated Clostridium perfringens strains and exploratory caecal microbiome investigation reveals key factors linked to poultry necrotic enteritis. Animal Microbiome (2019) 1: 12. https://doi.org/10.1186/s42523-019-0015-1.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Centers for Disease Control and prevention. Fatal foodbome Clostridium perfringens illness at a state psychiatric hospital – Louisiana, 2010. MMWR Morb Mortal Wkly Rep. 2012; 61 (32): 605–8.</mixed-citation><mixed-citation xml:lang="en">Centers for Disease Control and prevention. Fatal foodbome Clostridium perfringens illness at a state psychiatric hospital – Louisiana, 2010. MMWR Morb Mortal Wkly Rep. 2012; 61 (32): 605–8.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Freedman J. C., Evans D. R., McClane B. A. CodY promotes sporulation and enterotoxin production by Clostridium perfringens type A strain SM101. Infect. Immun. 2017; 85 (3): e00855–16. https://doi.org/10.1128/iai.00855-16.</mixed-citation><mixed-citation xml:lang="en">Li J., Freedman J. C., Evans D. R., McClane B. A. CodY promotes sporulation and enterotoxin production by Clostridium perfringens type A strain SM101. Infect. Immun. 2017; 85 (3): e00855–16. https://doi.org/10.1128/iai.00855-16.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gibert M., Jolivet-Reynaud C., Popoff M. R. Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene. 1997; 203 (1): 65–73. https://doi.org/10.1016/s03781119(97)00493-9.</mixed-citation><mixed-citation xml:lang="en">Gibert M., Jolivet-Reynaud C., Popoff M. R. Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene. 1997; 203 (1): 65–73. https://doi.org/10.1016/s03781119(97)00493-9.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Llanco LA., Nakano V., Avila-Campos M. J. Sialidase production and genetic diversity in Clostridium perfringens type A isolated from chicken with necrotic enteritis in Brazil. Curr. Microbiol. 2015; 70 (3): 330–7. https://doi.org/10.1007/s00284-0140722-5.</mixed-citation><mixed-citation xml:lang="en">Llanco LA., Nakano V., Avila-Campos M. J. Sialidase production and genetic diversity in Clostridium perfringens type A isolated from chicken with necrotic enteritis in Brazil. Curr. Microbiol. 2015; 70 (3): 330–7. https://doi.org/10.1007/s00284-0140722-5.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., McClane B. A. NanI sialidase can support the growth and survival of Clostridium perfringens strain F4969 using sialyated host macromolecules (Mucin) or Caco‑2 cells. Infect. Immun. 2018; 86(2): e00547–17. https://doi.org/10.1128/iai.00547-17.</mixed-citation><mixed-citation xml:lang="en">Li J., McClane B. A. NanI sialidase can support the growth and survival of Clostridium perfringens strain F4969 using sialyated host macromolecules (Mucin) or Caco‑2 cells. Infect. Immun. 2018; 86(2): e00547–17. https://doi.org/10.1128/iai.00547-17.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
